These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25175974)
1. The adenosine neuromodulation system in schizophrenia. Rial D; Lara DR; Cunha RA Int Rev Neurobiol; 2014; 119():395-449. PubMed ID: 25175974 [TBL] [Abstract][Full Text] [Related]
2. Adenosine receptor control of cognition in normal and disease. Chen JF Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970 [TBL] [Abstract][Full Text] [Related]
3. How does adenosine control neuronal dysfunction and neurodegeneration? Cunha RA J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148 [TBL] [Abstract][Full Text] [Related]
4. Adenosine receptors in cerebral ischemia. Melani A; Pugliese AM; Pedata F Int Rev Neurobiol; 2014; 119():309-48. PubMed ID: 25175971 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of striatal adenosine A(2A) receptors in schizophrenia. Deckert J; Brenner M; Durany N; Zöchling R; Paulus W; Ransmayr G; Tatschner T; Danielczyk W; Jellinger K; Riederer P Neuroreport; 2003 Mar; 14(3):313-6. PubMed ID: 12634474 [TBL] [Abstract][Full Text] [Related]
6. Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Boison D; Singer P; Shen HY; Feldon J; Yee BK Neuropharmacology; 2012 Mar; 62(3):1527-43. PubMed ID: 21315743 [TBL] [Abstract][Full Text] [Related]
7. Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Cunha RA Neurochem Int; 2008 Jan; 52(1-2):65-72. PubMed ID: 17664029 [TBL] [Abstract][Full Text] [Related]
8. Purinergic receptors in psychiatric disorders. Krügel U Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371 [TBL] [Abstract][Full Text] [Related]
12. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Fredholm BB Pharmacol Toxicol; 1995 Feb; 76(2):93-101. PubMed ID: 7746802 [TBL] [Abstract][Full Text] [Related]
13. Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease. Morin N; Di Paolo T Int Rev Neurobiol; 2014; 119():151-67. PubMed ID: 25175965 [TBL] [Abstract][Full Text] [Related]
14. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists. Dixon DA; Fenix LA; Kim DM; Raffa RB Ann Pharmacother; 1999 Apr; 33(4):480-8. PubMed ID: 10332540 [TBL] [Abstract][Full Text] [Related]
15. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia. Kase H Biosci Biotechnol Biochem; 2001 Jul; 65(7):1447-57. PubMed ID: 11515525 [TBL] [Abstract][Full Text] [Related]
16. Modulation and metamodulation of synapses by adenosine. Ribeiro JA; Sebastião AM Acta Physiol (Oxf); 2010 Jun; 199(2):161-9. PubMed ID: 20345418 [TBL] [Abstract][Full Text] [Related]
17. Effects of chronic administration of adenosine antagonists on adenosine A1 and A2a receptors in mouse brain. Traversa U; Rosati AM; Florio C; Vertua R In Vivo; 1994; 8(6):1073-8. PubMed ID: 7772740 [TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Ribeiro JA Eur J Pharmacol; 1999 Jun; 375(1-3):101-13. PubMed ID: 10443568 [TBL] [Abstract][Full Text] [Related]
19. Adenosine and related drugs in brain diseases: present and future in clinical trials. Lopes LV; Sebastião AM; Ribeiro JA Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493 [TBL] [Abstract][Full Text] [Related]
20. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors. Dalpiaz A; Gessi S; Varani K; Borea PA Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]